Cystatin C and Its Role in Arthritis Development
Author Information
Author(s): Bäcklund Alexandra, Holmdahl Meirav, Mattsson Ragnar, Håkansson Katarina, Lindström Veronica, Nandakumar Kutty Selva, Grubb Anders, Holmdahl Rikard
Primary Institution: Karolinska Institute
Hypothesis
Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development.
Conclusion
Cystatin C deficiency enhances the development of chronic arthritis by affecting the immune system's priming phase.
Supporting Evidence
- Cystatin C-deficient mice developed arthritis at a higher incidence and earlier onset than wild-type controls.
- The inflammatory phase of arthritis was not enhanced in cystatin C-deficient mice.
- Cystatin C-deficient mice showed increased T cell and B cell responses after immunization.
Takeaway
Mice without cystatin C get arthritis more easily and faster, showing that cystatin C helps protect against this disease.
Methodology
Cystatin C-deficient, sufficient, and heterozygous mice were tested for arthritis onset, incidence, and severity using collagen-induced arthritis models.
Potential Biases
Potential genetic influences from the mouse strains used could affect the results.
Limitations
The study primarily used a mouse model, which may not fully replicate human arthritis conditions.
Participant Demographics
Mice aged 8 to 16 weeks were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website